Patent · US Active

Treatments using a peptide and/or vaccine

US9999659B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Sylvia Brunner · Wien, AT
Gergana Galabova · Wien, AT
Gabriele Winsauer · Wien, AT
Erika Bilcikova · Bratislava, SK
Claudia Juno · Wien, AT
Pola Linzmayer-Hirt · Wiener Neudorf, AT
Birgit Schuh · Wien, AT
Guenther Staffler · Wien, AT

Key dates

Filing date	Dec 2, 2016
Grant date	Jun 19, 2018
Priority date	—
Expiry date	Dec 2, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a vaccine capable to induce the formation of antibodies directed to PCSK9 in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.